ACTIVE

PHARMAYOU WANZE

Financial year 2025 · Closed on 31/12/2025

Net result166,1 k €-31,2 %over 1 year
Gross margin962,3 k €-4,3 %over 1 year
Equity1,5 M €+12,8 %over 1 year
Workforce7,0 ETP-10,3 %over 1 year

Identity

Source · BCE/KBO

PHARMAYOU WANZE is a Public limited company incorporated in 1997. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wanze. It employs on average 7,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0462.316.945
Incorporation
31/12/1997
Legal form
Public limited company
Registered office
Chaussée de Wavre(WAN) 6
4520 Wanze · WallonieSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
7,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin962,3 k €1 M €650,3 k €596,7 k €770,5 k €
EBITDA421,6 k €486 k €155,1 k €91,7 k €309 k €
Operating result279,2 k €362,3 k €37,8 k €19,8 k €255,6 k €
Net result166,1 k €241,3 k €-180,6 €12,4 k €188,6 k €
Balance sheet
Equity1,5 M €1,3 M €1,1 M €1,1 M €1 M €
Total assets3,1 M €3,1 M €2,9 M €1,6 M €1,4 M €
Cash339,2 k €424,7 k €240,1 k €287,6 k €371,4 k €
Debts1,6 M €1,8 M €1,9 M €485,7 k €374,8 k €
Other
Workforce7,0 ETP7,8 ETP7,6 ETP8,6 ETP7,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Francis MOES

Director

Active
MOES

Director · 0473.330.504

Represented by Corinne BLISTIN

Active

Ended mandates

Corinne Blistin

Mandate · since 01 octobre 2018

Ended
MOES

Managing director · since 01 octobre 2018 · until 01 octobre 2024 · 0473.330.504

Represented by Corinne BLISTIN

Ended
MOES

Mandate · since 01 octobre 2018 · 0473.330.504

Ended
Francis MOES

Director · since 29 septembre 2018 · until 29 septembre 2024

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date31/08/202631/08/202530/08/202429/08/202325/08/202231/08/2021
General meeting29/05/202630/05/202531/05/202426/05/202327/05/202228/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202631/08/2026FrenchPDF
Abridged model31/12/202430/05/202531/08/2025FrenchPDF
Abridged model31/12/202331/05/202430/08/2024FrenchPDF
Abridged model31/12/202226/05/202329/08/2023FrenchPDF
Abridged model31/12/202127/05/202225/08/2022FrenchPDF
Abridged model31/12/202028/05/202131/08/2021FrenchPDF
Abridged model31/12/201929/05/202030/11/2020FrenchPDF
Abridged model31/12/201831/05/201924/09/2019FrenchPDF
Abridged model31/12/201725/05/201818/07/2018FrenchPDF
Abridged model31/12/201626/05/201720/07/2017FrenchPDF
Abridged model31/12/201527/05/201628/07/2016FrenchPDF
Abridged model31/12/201429/05/201524/08/2015FrenchPDF
Abridged model31/12/201330/05/201428/08/2014FrenchPDF
Abridged model31/12/201231/05/201304/07/2013FrenchPDF
Abridged model31/12/201125/05/201219/07/2012FrenchPDF
Abridged model31/12/201027/05/201124/06/2011FrenchPDF
Abridged model31/12/200928/05/201022/07/2010FrenchPDF
Abridged model31/12/200829/05/200916/07/2009FrenchPDF
Abridged model31/12/200730/05/200827/06/2008FrenchPDF
Abridged model31/12/200615/06/200705/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Francis MOES

Director

Active
MOES

Director · 0473.330.504

Represented by Corinne BLISTIN

Active

Ended mandates

Corinne Blistin

Mandate · since 01 octobre 2018

Ended
MOES

Managing director · since 01 octobre 2018 · until 01 octobre 2024 · 0473.330.504

Represented by Corinne BLISTIN

Ended
MOES

Mandate · since 01 octobre 2018 · 0473.330.504

Ended
Francis MOES

Director · since 29 septembre 2018 · until 29 septembre 2024

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office17/10/2024
    SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
    PDF
  • Mandates22/02/2024
    DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/10/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates19/10/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/07/2018
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares22/01/2018
    CAPITAL, ACTIONS
    PDF
  • Capital / shares07/01/2014
    CAPITAL, ACTIONS
    PDF
  • Mandates05/03/2012
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025166,1 k €↓
  2. 2024
    Annual accounts 2024241,3 k €↑
  3. 2023
    Annual accounts 2023-180,6 €↓
  4. 2023
    Name changePHARMAYOU WANZE
  5. 2022
    Annual accounts 202212,4 k €↓
  6. 2021
    Annual accounts 2021188,6 k €↑
  7. 2021
    Name changePHARMACIE PIRENNE
  8. 2020
    Annual accounts 202010,7 k €↓
  9. 2019
    Annual accounts 201963,8 k €↓
  10. 2018
    Annual accounts 2018163,2 k €↓
  11. 2017
    Annual accounts 2017170,8 k €↓
  12. 2016
    Annual accounts 2016195,4 k €↑
  13. 2015
    Annual accounts 20152,1 k €↓
  14. 2014
    Annual accounts 2014494,4 k €↑
  15. 2013
    Annual accounts 2013228,6 k €↑
  16. 2012
    Annual accounts 2012185,9 k €↓
  17. 2011
    Annual accounts 2011212,9 k €↑
  18. 2010
    Annual accounts 2010178,7 k €↓
  19. 2009
    Annual accounts 2009185,6 k €↑
  20. 2008
    Annual accounts 2008168,2 k €↑
  21. 2007
    Annual accounts 2007105,4 k €↑
  22. 2006
    Annual accounts 200691,9 k €
  23. 31/12/1997
    IncorporationPublic limited company